STOCK TITAN

Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

AGENUS INC (AGEN) amended a key debt facility through its subsidiary Agenus West, LLC by entering into a Second Loan Modification Agreement with Ocean 1181 LLC. The Borrower issued a Third Amended and Restated Promissory Note that keeps the outstanding principal at $24,750,000, extends the maturity date to November 30, 2029, and sets the interest rate at 13.0% per annum through maturity.

Monthly interest will continue to be paid one-half in cash and one-half in Agenus common stock. The Borrower will pay an extension fee of $247,500, also one-half in cash and one-half in common stock. Shares issued to the lender in connection with this modification are expected to rely on exemptions from registration under Section 4(a)(2) of the Securities Act and/or Regulation D.

Positive

  • $24,750,000 debt maturity extended to November 30, 2029, providing longer-term financing stability under the amended promissory note.

Negative

  • Debt continues at a relatively high 13.0% per annum interest rate, with ongoing interest and a $247,500 extension fee partly paid in stock, adding financing cost and equity issuance.
Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Outstanding principal $24,750,000 Principal amount under the Third Amended and Restated Promissory Note
Interest rate 13.0% per annum Interest on the amended loan through maturity
Maturity date November 30, 2029 New maturity of the Third Amended and Restated Promissory Note
Extension fee $247,500 Fee payable to the lender, half in cash and half in common stock
Interest payment mix 50% cash / 50% stock Monthly interest payment structure under the amended loan
Second Loan Modification Agreement financial
"entered into a Second Loan Modification Agreement with Ocean 1181 LLC"
Third Amended and Restated Promissory Note financial
"the Borrower executed and delivered to the Lender a Third Amended and Restated Promissory Note"
Section 4(a)(2) regulatory
"pursuant to Section 4(a)(2) thereof and/or Regulation D promulgated thereunder"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
Regulation D regulatory
"pursuant to Section 4(a)(2) thereof and/or Regulation D promulgated thereunder"
Regulation D is a set of rules that govern how companies can raise money from investors without going through the full process required for public stock offerings. It provides simplified options for private placements, making it easier for companies to seek investments from a smaller group of investors. For investors, it offers opportunities to invest in private companies, often with fewer restrictions, but also with different levels of risk and disclosure.

FAQ

What debt change did AGEN (Agenus Inc.) announce in this 8-K?

Agenus Inc. amended a loan via a Third Amended and Restated Promissory Note, keeping principal at $24,750,000, extending maturity to November 30, 2029, and setting the interest rate at 13.0% per annum through maturity.

What is the new maturity date of Agenus Inc. (AGEN)'s amended loan?

The amended promissory note for Agenus Inc.’s subsidiary loan now matures on November 30, 2029. This extension comes under a Second Loan Modification Agreement with Ocean 1181 LLC, replacing prior versions of the note in full.

What interest rate does AGEN pay on the amended promissory note?

The Third Amended and Restated Promissory Note bears interest at 13.0% per annum through maturity. Monthly interest payments are structured so that one-half is paid in cash and one-half is paid in shares of Agenus Inc.’s common stock.

How much is the extension fee on Agenus Inc. (AGEN)'s loan modification?

The Borrower agreed to pay an extension fee of $247,500 to the lender. This fee will be settled with one-half paid in cash and one-half paid in shares of Agenus Inc.’s common stock under the modified loan terms.

Will AGEN issue unregistered shares under this loan modification?

Yes. Shares of Agenus Inc.’s common stock issuable to the lender are expected to be issued as unregistered securities in reliance on Section 4(a)(2) of the Securities Act and/or Regulation D exemptions.

How are monthly interest payments structured on AGEN’s modified loan?

Monthly interest on the $24,750,000 loan will continue to be paid one-half in cash and one-half in Agenus common stock. This blended payment structure remains in place under the Third Amended and Restated Promissory Note.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false000109897200010989722026-08-122026-08-12

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 12, 2026

 

 

AGENUS INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

000-29089

06-1562417

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

3 Forbes Road

 

Lexington, Massachusetts

 

02421

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 781 674-4400

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value per share

 

AGEN

 

The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 1.01 Entry into a Material Definitive Agreement.

On August 12, 2026, Agenus West, LLC (the “Borrower”), a subsidiary of Agenus Inc. (the “Company”), and the Company, as guarantor, entered into a Second Loan Modification Agreement (the “Loan Modification Agreement”) with Ocean 1181 LLC (the “Lender”) relating to the promissory note previously entered into with the Lender on November 26, 2024, as previously amended and restated, and previously disclosed by the Company in its Current Report on Form 8-K filed with the Securities and Exchange Commission on November 27, 2024 (the “Note”).

 

Pursuant to the Loan Modification Agreement, the Borrower executed and delivered to the Lender a Third Amended and Restated Promissory Note, which amends and restates the Note in its entirety. Pursuant to the Third Amended and Restated Promissory Note and related loan documents, the outstanding principal amount remains $24,750,000, the maturity date was extended to November 30, 2029, and the loan bears interest at 13.0% per annum through maturity. Monthly interest payments will continue to be payable one-half in cash and one-half in shares of the Company’s common stock. In connection with the modification, the Borrower agreed to pay the Lender an extension fee of $247,500, payable one-half in cash and one-half in shares of the Company’s common stock.

 

Except as amended by the Loan Modification Agreement and related loan documents, the material terms and conditions of the Note remain unchanged and in full force and effect.

 

The foregoing summary is qualified by reference to the copies of the Loan Modification Agreement and related loan documents, which will be filed as exhibits to the Company’s next periodic report.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

To the extent required, the disclosure required by this item is included in Item 1.01 and is incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The disclosure required by this item is included in Item 1.01 and is incorporated herein by reference.

 

The shares of the Company’s common stock issuable to the Lender pursuant to the Loan Modification Agreement and related loan documents are expected to be issued in transactions exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D promulgated thereunder.

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

August 18, 2026

By:

/s/ Garo H. Armen

 

 

 

Garo H. Armen, Chairman and CEO

 


Filing Exhibits & Attachments

1 document